Crossmark

Surgical versus percutaneous isolated pelvic perfusion (IPP) for advanced melanoma: comparison in terms of melphalan pharmacokinetic pelvic bio-availability

Crossref DOI link: https://doi.org/10.1186/s13104-017-2738-y

Published Online: 2017-08-15

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Guadagni, Stefano http://orcid.org/0000-0001-8525-084X
Palumbo, Giancarlo

Fiorentini, Giammaria

Clementi, Marco

Marsili, Luca

Giordano, Aldo Victor

Masedu, Francesco

Valenti, Marco
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct01920516 at ClinicalTrials.gov

Documents that mention this clinical trial

Circulating tumour cell liquid biopsy in selecting therapy for recurrent cutaneous melanoma with locoregional pelvic metastases: a pilot study
https://doi.org/10.1186/s13104-020-05021-5

Surgical versus percutaneous isolated pelvic perfusion (IPP) for advanced melanoma: comparison in terms of melphalan pharmacokinetic pelvic bio-availability
https://doi.org/10.1186/s13104-017-2738-y
License Information

Text and Data Mining valid from 2017-08-15

Version of Record valid from 2017-08-15
More Information

Article History

Received: 13 January 2017

Accepted: 7 August 2017

First Online: 15 August 2017

Document is current

Any future updates will be listed below